期刊文献+

宫颈癌组织中HER-2/neu和Ras表达的意义 被引量:6

Expressions and significance of HER-2/neu,Ras oncogenes in cervical carcinoma
下载PDF
导出
摘要 目的研究HER-2/neu(c-erbB-2)和Ras癌基因在宫颈腺癌和鳞癌中的表达及意义,探讨其在宫颈癌发生发展中的作用.方法采用免疫组化SP法检测正常宫颈组织20例、宫颈腺癌40例及鳞癌45例中P185c-erbB-2和P21ras蛋白的表达.结果在正常宫颈组织中P185c-erbB-2和P21ras蛋白均不表达,在鳞癌中阳性表达率分别为13.3%和28.9%,在腺癌中阳性表达率分别为27.5%和55.0%.P21ras在宫颈腺癌及鳞癌组表达均显著高于正常组(P<0.0125),同时腺癌组明显高于鳞癌组;P185c-erbB-2在腺癌中的阳性表达率较正常组高(P<0.0125),鳞癌组与正常组及腺癌组与鳞癌组相比差异不显著(P>0.0125).P185c-erbB-2和P21ras蛋白的阳性表达率与细胞分化级别有明显相关性(P<0.0125),与临床分期、淋巴结转移无关;两者在宫颈癌组织中的表达显著相关(P<0.01,kappa=0.405,χ2=53.21).结论在宫颈癌中P185c-erbB-2和P21ras蛋白同时过表达可能是宫颈癌的发病机制之一,过表达现象在宫颈腺癌中尤为突出. AIM: To detect the expressions of HER-2/neu (c- erbB-2) and Ras oncogenes in cervical carcinoma, and to evaluate the roles of HER-2/neu and Ras in the genesis and development of cervix squamous cell carcinoma and adenocarcinoma. METHODS: The SP immunohistochemical method was used to detect the expressions of P185^c-erbB-2 and P21^ras proteins in 20 cases of normal cervix tissue, 40 cases of adenocarcinoma and 45 cases of squamous cell carcinoma. RESULTS: P185^c-erbB-2 and P21^ras proteins were not observed in normal cervixes. Positive expression rates of the two proteins were 13.3% , 28.9% in cervix squamous cell carcinoma, and 27.5% , 55.0% in cervix adenocarcinoma. Compared with normal cervix tissue, P21^ras positive expression in adenocarcinoma and squamous cell carcinoma was different significantly ( P 〈0. 0125 ) , and the expression between adenocarcinoma and squamous cell carcinoma had obvious difference ;The positive expression of P185^c-ebB-2 in adenocarcinoma was higher than the normal tissue significantly (P 〈 0. 0125 ). The difference between squamous cell carcinoma and normal tissue, or adenocarcinoma and squamous cell carcinoma was not significant (P 〉 0. 0125). P185^c-erbB-2 and P21^ras proteins were correlated with the differentiation degree of carcinoma closely (P 〈 0.0125). No correlation was found between positive expression and clinical stage, nor lymphatic metastasis. In addition, there was an obvious correlation between P185^c-erbB-2 and P21^ras in cervix cancer(P 〈0.01,kappa =0.405,)X^2 =53. 21). CONCLUSION: P185^c-erbB-2 and P21^ras proteins were overexpressed in cervix cancer at the same time, especially in cervical adenocarcinoma, which may be one of mechanisms of carcinogenesis.
出处 《第四军医大学学报》 北大核心 2006年第19期1805-1807,共3页 Journal of the Fourth Military Medical University
关键词 宫颈肿瘤 HER-2/NEU RAS 免疫组织化学 cervical neoplasm her-2/neu ras immunohistochemistry
  • 相关文献

参考文献8

  • 1Davy ML,Dodd TJ,Luke CG,et al.Cervical Cancer:Effect of glandular cell type on prognosis,treatment,and survival[J].Obstetrics Gynecol,2003,101:38-45. 被引量:1
  • 2Chavez-Blanco A,Perez-Sanchez V,Gonzalez-Fierro A,et al.HER-2 expression in cervical cancer as a potential therapeutic target[J].BMC Cancer,2004,4:59. 被引量:1
  • 3惠延平,黄高升,王文亮,王映梅,朱晓慧,马福成.胃癌及其癌前病变中ras,c-erbB-2,p53癌基因产物的表达[J].第四军医大学学报,2001,22(3):220-223. 被引量:8
  • 4Livasy CA,Reading FC,Moore DT,et al.EGFR expression and HER2/neu overexpression /amplification in endometrial carcinosarcoma[J].Gynecol Oncol,2006,100(1):101-106. 被引量:1
  • 5Lopes MA,da Cruz Perez DE,de Abreu Alves F,et al.Clinicopathologic and immunohistochemical study of intraoral mucoepidermoid carcinoma[J].Otolaryngol Head Neck Surg,2006,134(4):622-626. 被引量:1
  • 6Bahnassi AA,Zekri AR,El-Houssini S,et al.Hepatitis C virus-NS3P in relation to p53,p21waf,mdm2,p21-ras and c-erbB2 in hepatocarcinogenesis[J].Gastroenterol Hepatol,2005,20(11):1731-1740. 被引量:1
  • 7Semczuk A,Postawski K,Przadka D,et al.K-ras gene point mutations and p21ras immunostaining in human ovarian tumors[J].Gynaecol Oncol,2004,25(4):484-488. 被引量:1
  • 8Przybojewska B,Rydzynski K,Stepnik M,et al.Immunohistochemical evaluation of P21ras and P53 proteins expression in human non-small-cell lung cancers[J].Neoplasma,2003,50(3):198-203. 被引量:1

二级参考文献5

  • 1Isogaki J,Cancer Detect Prev,1999年,23卷,3期,204页 被引量:1
  • 2Wu M S,Br J Cancer,1998年,78卷,7期,971页 被引量:1
  • 3Hui Y P,第四军医大学学报,1997年,18卷,1期,54页 被引量:1
  • 4Wang J,第二军医大学学报,1994年,15卷,1期,20页 被引量:1
  • 5Zhang Y C,中国医科大学学报,1987年,16卷,1期,16页 被引量:1

共引文献7

同被引文献48

  • 1李长民,庄如锦,李佩玲,关咏梅.p27和cyclinE在宫颈癌中的表达及其临床意义[J].中国现代医学杂志,2005,15(11):1651-1654. 被引量:5
  • 2蒋琳,冯静,吴文芳,杨东玲,阎锡蕴.抗HER2-hTNF-α新型免疫毒素的制备及功能研究[J].生物化学与生物物理进展,2005,32(9):850-856. 被引量:1
  • 3韦毓,庞朗,冯秀英.PTEN、CyclinE与子宫内膜癌[J].柳州医学,2006,19(2):101-104. 被引量:1
  • 4刘玉,辛晓燕,王巍,张潍.宫颈癌组织与细胞中HER-2/neu和Ras的表达及意义[J].现代肿瘤医学,2007,15(1):69-72. 被引量:3
  • 5Verri E, Guglielmini P, Puntoni M, et al. HER2/neu oneoprotein over expression in epithelial ovarian cancer: Evaluation of its preva- lence and prognostic significance [ J ]. Oncology, 2005, 68 (2 - 3 ) : 154 - 161. 被引量:1
  • 6Szelachowska J, Jelen M, Kornafel J. Prognostic significance of intracellular laminin and Her2/neu overexpression in non-small cell lung cancer[J]. Anticancer Res,2006,26(5B) :3871 -3876. 被引量:1
  • 7Curigliano G, Spitaleri G, Pietri E, et al. Breast cancer vaccines: A clinical reality or fairy tale? [J]. Ann Oncol, 2006,17:750 -762. 被引量:1
  • 8Bernards RA, Destree S, Mc Kenzie S, et al. Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector [ J]. Proc Natl Acad Sci USA, 1987, 84:6854 -6858. 被引量:1
  • 9Disis ML, Calenoff E, Mclaughlin G, et al. Existent T cell and antibody immunity to HER-2/neu protein in patients with breast cancer [J]. Cancer Res,1994,54:16. 被引量:1
  • 10Renard VL, Sonderbye K, Ebbeho J, et al. HER-2 DNA and protein vaccines containing potent Th cell epitopes induce distinct protective and therapeutic antitumor responses in HER-2 transgenic mice [J]. J Immunol, 2003,171:1588 - 1595. 被引量:1

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部